A Dose-ranging Study of Fluticasone Furoate (FF)

PHASE2CompletedINTERVENTIONAL
Enrollment

597

Participants

Timeline

Start Date

March 28, 2012

Primary Completion Date

September 24, 2014

Study Completion Date

September 24, 2014

Conditions
Asthma
Interventions
DRUG

Fluticasone Furoate

current asthma medicine

DRUG

Fluticasone Propionate

Fluticasone propionate

DRUG

Placebo

placebo

Trial Locations (139)

1000

GSK Investigational Site, Manila

1003

GSK Investigational Site, Manila

1113

GSK Investigational Site, Quezon City

1501

GSK Investigational Site, Middelburg

4002

GSK Investigational Site, Plovdiv

4003

GSK Investigational Site, Plovdiv

7000

GSK Investigational Site, Rousse

7500

GSK Investigational Site, Panorama

7764

GSK Investigational Site, CapeTown

10785

GSK Investigational Site, Berlin

14830

GSK Investigational Site, Corning

15241

GSK Investigational Site, Pittsburgh

21021

GSK Investigational Site, Vinnytsia

21502

GSK Investigational Site, Geesthacht

22415

GSK Investigational Site, Hamburg

27607

GSK Investigational Site, Raleigh

29118

GSK Investigational Site, Orangeburg

29407

GSK Investigational Site, Charleston

31904

GSK Investigational Site, Columbus

32927

GSK Investigational Site, Cocoa

33173

GSK Investigational Site, Miami

33180

GSK Investigational Site, Aventura

37073

GSK Investigational Site, Göttingen

38302

GSK Investigational Site, Wolfenbüttel

42301

GSK Investigational Site, Owensboro

44100

GSK Investigational Site, Guadalajara

44718

GSK Investigational Site, Canton

44791

GSK Investigational Site, Bochum

45040

GSK Investigational Site, Zapopan

45231

GSK Investigational Site, Cincinnati

47533

GSK Investigational Site, Kleve-Materborn

48291

GSK Investigational Site, Telgte

49127

GSK Investigational Site, Stevensville

55441

GSK Investigational Site, Plymouth

58001

GSK Investigational Site, Chernivtsi

58070

GSK Investigational Site, Morelia

59063

GSK Investigational Site, Hamm

60596

GSK Investigational Site, Frankfurt am Main

61093

GSK Investigational Site, Kharkiv

61761

GSK Investigational Site, Normal

62269

GSK Investigational Site, Shiloh

63263

GSK Investigational Site, Neu-Isenburg

65203

GSK Investigational Site, Columbia

65401

GSK Investigational Site, Rolla

65527

GSK Investigational Site, Niedernhausen

66215

GSK Investigational Site, Lenexa

68163

GSK Investigational Site, Mannheim

69063

GSK Investigational Site, Zaporizhia

69076

GSK Investigational Site, Zaporizhia

72205

GSK Investigational Site, Little Rock

73000

GSK Investigational Site, Kherson

73112

GSK Investigational Site, Oklahoma City

75230

GSK Investigational Site, Dallas

76018

GSK Investigational Site, Ivano-Frankivsk

76712

GSK Investigational Site, Waco

78229

GSK Investigational Site, San Antonio

78258

GSK Investigational Site, San Antonio

78750

GSK Investigational Site, Austin

79925

GSK Investigational Site, El Paso

83026

GSK Investigational Site, Rosenheim

83471

GSK Investigational Site, Berchtesgaden

83616

GSK Investigational Site, Eagle

86100

GSK Investigational Site, Villahermosa

90274

GSK Investigational Site, Rolling Hills Estates

90808

GSK Investigational Site, Long Beach

91000

GSK Investigational Site, Luhansk

92626

GSK Investigational Site, Costa Mesa

92647

GSK Investigational Site, Huntington Beach

92663

GSK Investigational Site, Newport Beach

92868

GSK Investigational Site, Orange

95034

GSK Investigational Site, Simferopol

97202

GSK Investigational Site, Portland

97408

GSK Investigational Site, Yevpatoriia

97504

GSK Investigational Site, Medford

98724

GSK Investigational Site, Neuhaus am Rennweg

119991

GSK Investigational Site, Moscow

150003

GSK Investigational Site, Yaroslavl

183031

GSK Investigational Site, Murmansk

194356

GSK Investigational Site, Saint Petersburg

394036

GSK Investigational Site, Voronezh

630091

GSK Investigational Site, Novosibirsk

654063

GSK Investigational Site, Novokuznetsk

675000

GSK Investigational Site, Blagoveshchensk

05403

GSK Investigational Site, South Burlington

Unknown

GSK Investigational Site, Sofia

GSK Investigational Site, Lima

0119

GSK Investigational Site, Tbilisi

0159

GSK Investigational Site, Tbilisi

0160

GSK Investigational Site, Tbilisi

0186

GSK Investigational Site, Tbilisi

01307

GSK Investigational Site, Dresden

260-0001

GSK Investigational Site, Chiba

811-1394

GSK Investigational Site, Fukuoka

720-8520

GSK Investigational Site, Hiroshima

006-0831

GSK Investigational Site, Hokkaido

064-0821

GSK Investigational Site, Hokkaido

653-0021

GSK Investigational Site, Hyōgo

762-0031

GSK Investigational Site, Kagawa

514-0125

GSK Investigational Site, Mie

583-8588

GSK Investigational Site, Osaka

154-0017

GSK Investigational Site, Tokyo

157-0066

GSK Investigational Site, Tokyo

158-0097

GSK Investigational Site, Tokyo

646-8558

GSK Investigational Site, Wakayama

LV5403

GSK Investigational Site, Daugavpils

LV-4601

GSK Investigational Site, Rēzekne

LV 1003

GSK Investigational Site, Riga

LV 1004

GSK Investigational Site, Riga

LV1011

GSK Investigational Site, Riga

06720

GSK Investigational Site, Mexico City

07760

GSK Investigational Site, Mexico City

04530

GSK Investigational Site, México

Lima 27

GSK Investigational Site, Lima

GSK Investigational Site, Lima

Lima 41

GSK Investigational Site, San Borja

Lima 32

GSK Investigational Site, San Miguel

Lima 11

GSK Investigational Site, Lima

Lima 29

GSK Investigational Site, Lima

15-183

GSK Investigational Site, Bialystok

15-430

GSK Investigational Site, Bialystok

85-046

GSK Investigational Site, Bydgoszcz

39-200

GSK Investigational Site, Dębica

25-017

GSK Investigational Site, Kielce

93-513

GSK Investigational Site, Lodz

20-089

GSK Investigational Site, Lublin

20-093

GSK Investigational Site, Lublin

20-552

GSK Investigational Site, Lublin

60-693

GSK Investigational Site, Poznan

33-100

GSK Investigational Site, Tarnów

00917

GSK Investigational Site, Hato Rey

SE-416 85

GSK Investigational Site, Gothenburg

SE-434 30

GSK Investigational Site, Kungsbacka

SE-701 85

GSK Investigational Site, Örebro

SE-118 83

GSK Investigational Site, Stockholm

SE171 76

GSK Investigational Site, Stockholm

SE-752 26

GSK Investigational Site, Uppsala

SE-621 84

GSK Investigational Site, Visby

03680

GSK Investigational Site, Kyiv

04050

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01563029 - A Dose-ranging Study of Fluticasone Furoate (FF) | Biotech Hunter | Biotech Hunter